Time Source Company Announcement
20 Aug 2021 11:08 AM Shield Therapeutics (STX) - Focused on US marke...
20 Aug 2021 11:05 AM Second Price Monitoring Extn
20 Aug 2021 11:05 AM Second Price Monitoring Extn
20 Aug 2021 11:05 AM Second Price Monitoring Extn
20 Aug 2021 11:04 AM Holding(s) in Company
20 Aug 2021 11:00 AM Price Monitoring Extension
20 Aug 2021 11:00 AM Price Monitoring Extension
20 Aug 2021 11:00 AM Price Monitoring Extension
20 Aug 2021 10:55 AM Directorate Change
20 Aug 2021 10:46 AM Holding(s) in Company
20 Aug 2021 10:45 AM TotalEnergies to Introduce a 100% Renewable Fue...
20 Aug 2021 10:45 AM Holding(s) in Company
20 Aug 2021 10:41 AM Holding(s) in Company
20 Aug 2021 10:29 AM Portfolio Update
20 Aug 2021 10:27 AM Director/PDMR Shareholding
20 Aug 2021 10:21 AM Result of General Meeting
20 Aug 2021 10:15 AM PDMR Shareholdings
20 Aug 2021 10:01 AM Holding(s) in Company
20 Aug 2021 09:42 AM Director/PDMR Shareholding
20 Aug 2021 09:30 AM Director/PDMR Shareholding
20 Aug 2021 09:21 AM Portfolio Update
20 Aug 2021 09:05 AM Second Price Monitoring Extn
20 Aug 2021 09:05 AM Second Price Monitoring Extn
20 Aug 2021 09:05 AM Second Price Monitoring Extn
20 Aug 2021 09:00 AM Price Monitoring Extension
20 Aug 2021 09:00 AM Price Monitoring Extension
20 Aug 2021 09:00 AM Price Monitoring Extension
20 Aug 2021 09:00 AM Compliance with Market Abuse Regulation
20 Aug 2021 08:58 AM Kun-Manie TEO Submitted For Review
20 Aug 2021 08:53 AM Date of announcement of 1H2021 FR
20 Aug 2021 08:43 AM Result of Placing and PrimaryBid Offer
20 Aug 2021 08:19 AM Directors/PDMRs Shareholding
20 Aug 2021 08:16 AM Monthly Report
20 Aug 2021 08:00 AM Edison issues review on Aberdeen Latin American
20 Aug 2021 08:00 AM Circular & Notice of GM
20 Aug 2021 07:44 AM Director/PDMR Shareholding
20 Aug 2021 07:34 AM Result of AGM
20 Aug 2021 07:30 AM Transaction in Own Shares
20 Aug 2021 07:15 AM Notification of Major Shareholding - Delta Dunia
20 Aug 2021 07:15 AM Business Update
20 Aug 2021 07:15 AM Transaction in Own Shares
20 Aug 2021 07:05 AM Update on Ultomiris Phase III ALS trial
20 Aug 2021 07:01 AM Share Buyback Programme
20 Aug 2021 07:01 AM TR1: Notification of Major Interest in Shares
20 Aug 2021 07:00 AM AZD7442 prophylaxis trial met primary endpoint
20 Aug 2021 07:00 AM Filing of Registration Stmt for Proposed Offering
20 Aug 2021 07:00 AM TR-1
20 Aug 2021 07:00 AM 2nd Quarter 2021 Factsheets - all share classes
20 Aug 2021 07:00 AM Option awards and PDMR Dealing
20 Aug 2021 07:00 AM Conversion of loan facility and Issue of Equity
UK 100

Latest directors dealings